About this trial
The purpose of this study is to understand the impact of palliative and ablative RT treatment on HRQOL in patients with metastatic disease using the electronic patient-reported outcome platform ONCOpatient. Data will be collected at 4 timepoints: at the pre-treatment, final treatment and 4-weeks and 3 months post-treatment.
Patient Profile
Participants 18 years or older, due to receive palliative intent radiotherapy with conventional or stereotactic body radiotherapy techniques, willing to complete questionnaires with a prognosis of at least 3 months.
Where’s this trial being run?
Cork University Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.
Print this pageFor more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | HRQOL |
|---|---|
| Number: | 24-101 |
| Full Title: | HRQOL |
| Principal Investigator: | Prof. Aisling Barry |
|---|---|
| Type: | In-House |
| Sponsor: | |
| Recruitment Started: |
Global: Ireland: |
| Global Recruitment Target: | 150 |
|---|---|
| Ireland Recruitment Target: | 150 |